Users Stopping Slimming Medications Gain Back Pounds Far More Rapidly Than Dieters

A recent study reveals that patients who discontinue new GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who halt traditional lifestyle programs.

Research printed in a major health publication points out that while overweight individuals frequently drop about a fifth of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month once they quit.

"Individuals using such medications must be informed of the potential of fast weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to starting weight within about 18 months.

Comparing Therapies

The research, which examined 37 of trials involving over 9,000 of patients, contrasted the results of the injectable medications with conventional dieting.

Scientists note that people who lose weight through dieting usually see a less rapid weight regain—around 100 grams monthly—post-intervention.

The Reason for the Quick Rebound

Doctors believe the mode of action of the injections explains the accelerated weight return.

These medications copy a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing the hormone levels far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication leads to hunger is no longer kept in check, making overeating much more probable."

A Chronic Issue?

The NHS recommend the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals say that, considering the likelihood of relapse, the therapy might need to be ongoing.

This perspective is supported by drug manufacturers, who note that the findings "underscore the persistent nature of excess weight," comparing it to managing diseases like hypertension.

User Experiences

Users who have stopped the jabs explain a intense resurgence of cravings.

"I experienced a trigger that goes on and you become starving," said a patient.

The struggle is worsened if patients have not adopted permanent lifestyle or habit modifications during treatment.

Growing Use

Figures show that a significant number of people in the UK have tried these injections in the past year, with interest remaining high.

• Adoption is greater among females than males.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Ultimately, experts caution that while the jabs are effective agents for shedding pounds, they are not a permanent solution and long-term success likely depends on integrated lifestyle management.